(XTB) X Trade Brokers Dom - Ratings and Ratios
ETF, Stocks, Bonds, Commodities, Indices, Currency Derivatives
XTB EPS (Earnings per Share)
XTB Revenue
Description: XTB X Trade Brokers Dom
XTB S.A. is a leading brokerage firm operating in multiple regions, including Central and Eastern Europe, Western Europe, Latin America, and the Middle East, offering a diverse range of financial instruments such as ETFs, currency derivatives, commodities, indices, stocks, and bonds. The company operates through two main segments: Retail Operations, catering to individual customers, and Institutional Activity, providing trading infrastructure and services to institutional clients.
With a strong presence in the brokerage industry, XTB S.A. has demonstrated its ability to adapt and grow, having been founded in 2002 and headquartered in Warsaw, Poland. As a subsidiary of XXZW Investment Group S.A., the company has a solid backing. Its website, https://www.xtb.com, serves as a hub for information and services.
From a financial perspective, XTB S.A.s market capitalization stands at approximately 8415.75M PLN, indicating a substantial market presence. The companys Return on Equity (RoE) of 39.32% suggests a high level of profitability, making it an attractive investment opportunity. Additionally, the Price-to-Earnings (P/E) ratio of 11.27 indicates that the stock may be undervalued relative to its earnings, presenting a potential buying opportunity.
To further evaluate XTB S.A.s performance, other key metrics can be considered. For instance, its revenue growth, net profit margin, and dividend yield can provide insights into the companys financial health and investor returns. Moreover, industry comparisons can be made by analyzing the companys performance relative to its peers in the Investment Banking & Brokerage sub-industry.
Some additional KPIs that can be used to assess XTB S.A.s performance include its debt-to-equity ratio, interest coverage ratio, and operating cash flow margin. These metrics can help investors and analysts better understand the companys financial leverage, ability to meet its interest obligations, and cash generation capabilities.
XTB Stock Overview
| Market Cap in USD | 2,537m |
| Sub-Industry | Investment Banking & Brokerage |
| IPO / Inception |
XTB Stock Ratings
| Growth Rating | 92.0% |
| Fundamental | 73.3% |
| Dividend Rating | 88.2% |
| Return 12m vs S&P 500 | 11.4% |
| Analyst Rating | - |
XTB Dividends
| Dividend Yield 12m | 7.59% |
| Yield on Cost 5y | 53.96% |
| Annual Growth 5y | 83.70% |
| Payout Consistency | 82.9% |
| Payout Ratio | 109.0% |
XTB Growth Ratios
| Growth Correlation 3m | 29.9% |
| Growth Correlation 12m | 80.9% |
| Growth Correlation 5y | 96.7% |
| CAGR 5y | 67.29% |
| CAGR/Max DD 3y | 2.36 |
| CAGR/Mean DD 3y | 11.21 |
| Sharpe Ratio 12m | 0.11 |
| Alpha | 17.72 |
| Beta | 0.587 |
| Volatility | 38.94% |
| Current Volume | 126.9k |
| Average Volume 20d | 176.5k |
| Stop Loss | 73.2 (-3.3%) |
| Signal | -0.45 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (804.0m TTM) > 0 and > 6% of Revenue (6% = 124.2m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA -5.73pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 88.23% (prev 96.10%; Δ -7.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 706.1m <= Net Income 804.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.92b) to EBITDA (904.7m) ratio: 4.33 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.34 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (117.5m) change vs 12m ago 0.03% (target <= -2.0% for YES) |
| Gross Margin 80.72% (prev 80.95%; Δ -0.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 33.09% (prev 33.11%; Δ -0.02pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.99 (EBITDA TTM 904.7m / Interest Expense TTM 100.7m) >= 6 (WARN >= 3) |
Altman Z'' 2.88
| (A) 0.25 = (Total Current Assets 7.24b - Total Current Liabilities 5.41b) / Total Assets 7.32b |
| (B) 0.06 = Retained Earnings (Balance) 425.4m / Total Assets 7.32b |
| (C) 0.14 = EBIT TTM 904.7m / Avg Total Assets 6.26b |
| (D) 0.08 = Book Value of Equity 425.4m / Total Liabilities 5.55b |
| Total Rating: 2.88 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 73.34
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield 5.20% = 2.60 |
| 3. FCF Margin 32.97% = 7.50 |
| 4. Debt/Equity 3.15 = -0.99 |
| 5. Debt/Ebitda 6.14 = -2.50 |
| 6. ROIC - WACC 32.65% = 12.50 |
| 7. RoE 41.40% = 2.50 |
| 8. Rev. Trend 57.80% = 2.89 |
| 9. Rev. CAGR 13.11% = 1.64 |
| 10. EPS Trend 16.13% = 0.40 |
| 11. EPS CAGR -5.61% = -0.70 |
What is the price of XTB shares?
Over the past week, the price has changed by -1.20%, over one month by -1.25%, over three months by +3.46% and over the past year by +32.59%.
Is X Trade Brokers Dom a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XTB is around 121.18 PLN . This means that XTB is currently undervalued and has a potential upside of +60.04% (Margin of Safety).
Is XTB a buy, sell or hold?
What are the forecasts/targets for the XTB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 74 | -2.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 129.8 | 71.4% |
XTB Fundamental Data Overview
Market Cap PLN = 9.20b (9.20b PLN * 1.0 PLN.PLN)
CCE Cash And Equivalents = 1.64b PLN (Cash only, last quarter)
P/E Trailing = 11.4532
P/S = 4.4128
P/B = 5.2361
Beta = 0.242
Revenue TTM = 2.07b PLN
EBIT TTM = 904.7m PLN
EBITDA TTM = 904.7m PLN
Long Term Debt = 144.7m PLN (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 5.41b PLN (from totalCurrentLiabilities, last quarter)
Debt = 5.55b PLN (Calculated: Short Term 5.41b + Long Term 144.7m)
Net Debt = 3.92b PLN (calculated as Total Debt 5.55b - CCE 1.64b)
Enterprise Value = 13.12b PLN (9.20b + Debt 5.55b - CCE 1.64b)
Interest Coverage Ratio = 8.99 (Ebit TTM 904.7m / Interest Expense TTM 100.7m)
FCF Yield = 5.20% (FCF TTM 682.6m / Enterprise Value 13.12b)
FCF Margin = 32.97% (FCF TTM 682.6m / Revenue TTM 2.07b)
Net Margin = 38.83% (Net Income TTM 804.0m / Revenue TTM 2.07b)
Gross Margin = 80.72% ((Revenue TTM 2.07b - Cost of Revenue TTM 399.1m) / Revenue TTM)
Tobins Q-Ratio = 30.84 (Enterprise Value 13.12b / Book Value Of Equity 425.4m)
Interest Expense / Debt = 1.04% (Interest Expense 57.7m / Debt 5.55b)
Taxrate = 18.27% (191.6m / 1.05b)
NOPAT = 739.3m (EBIT 904.7m * (1 - 18.27%))
Current Ratio = 1.34 (Total Current Assets 7.24b / Total Current Liabilities 5.41b)
Debt / Equity = 3.15 (Debt 5.55b / last Quarter total Stockholder Equity 1.76b)
Debt / EBITDA = 6.14 (Net Debt 3.92b / EBITDA 904.7m)
Debt / FCF = 8.14 (Debt 5.55b / FCF TTM 682.6m)
Total Stockholder Equity = 1.94b (last 4 quarters mean)
RoA = 10.99% (Net Income 804.0m, Total Assets 7.32b )
RoE = 41.40% (Net Income TTM 804.0m / Total Stockholder Equity 1.94b)
RoCE = 43.35% (Ebit 904.7m / (Equity 1.94b + L.T.Debt 144.7m))
RoIC = 38.07% (NOPAT 739.3m / Invested Capital 1.94b)
WACC = 5.42% (E(9.20b)/V(14.76b) * Re(8.18%)) + (D(5.55b)/V(14.76b) * Rd(1.04%) * (1-Tc(0.18)))
Shares Correlation 3-Years: -20.0 | Cagr: -0.00%
Discount Rate = 8.18% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 80.94% ; FCFE base≈722.7m ; Y1≈887.5m ; Y5≈1.50b
Fair Price DCF = 211.5 (DCF Value 24.85b / Shares Outstanding 117.5m; 5y FCF grow 24.40% → 3.0% )
Revenue Correlation: 57.80 | Revenue CAGR: 13.11%
Rev Growth-of-Growth: 6.59
EPS Correlation: 16.13 | EPS CAGR: -5.61%
EPS Growth-of-Growth: 5.08